Dataset Information


Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

ABSTRACT: Hepatitis B virus (HBV)-induced hepatitis and carcinogen-induced hepatocellular carcinoma (HCC) are associated with serum androgen concentration. However, how androgen or the androgen receptor (AR) contributes to HBV-induced hepatocarcinogenesis remains unclear. We found that hepatic AR promotes HBV-induced hepatocarcinogenesis in HBV transgenic mice that lack AR only in the liver hepatocytes (HBV-L-AR(-/y)). HBV-L-AR(-/y) mice that received a low dose of the carcinogen N'-N'-diethylnitrosamine (DEN) have a lower incidence of HCC and present with smaller tumor sizes, fewer foci formations, and less alpha-fetoprotein HCC marker than do their wild-type HBV-AR(+/y) littermates. We found that hepatic AR increases the HBV viral titer by enhancing HBV RNA transcription through direct binding to the androgen response element near the viral core promoter. This activity forms a positive feedback mechanism with cooperation with its downstream target gene HBx protein to promote hepatocarcinogenesis. Administration of a chemical compound that selectively degrades AR, ASC-J9, was able to suppress HCC tumor size in DEN-HBV-AR(+/y) mice. These results demonstrate that targeting the AR, rather than the androgen, could be developed as a new therapy to battle HBV-induced HCC.


PROVIDER: S-EPMC3032595 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2753209 | BioStudies
2012-01-01 | S-EPMC3673306 | BioStudies
2014-01-01 | S-EPMC4216744 | BioStudies
2020-01-01 | S-EPMC6959060 | BioStudies
2018-01-01 | S-EPMC5948202 | BioStudies
2017-01-01 | S-EPMC5620151 | BioStudies
2011-01-01 | S-EPMC3148736 | BioStudies
1000-01-01 | S-EPMC3562731 | BioStudies
2016-01-01 | S-EPMC4666840 | BioStudies
2011-01-01 | S-EPMC3208560 | BioStudies